Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital

被引:2
|
作者
Omona, Kizito [1 ]
Opiyo, Albert Mucha [2 ]
机构
[1] Uganda Martyrs Univ, Fac Hlth Sci, Kampala, Uganda
[2] Victory Hlth Serv, Dept Publ Hlth, Gulu City, Uganda
关键词
MDR-TB; tuberculosis; HIV; Gulu Regional Referral Hospital; EPIDEMIOLOGY;
D O I
10.4314/ahs.v23i3.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multi-drug resistant tuberculosis (MDR-TB) is increasingly recognized as emerging infectious disease of public health concern. Globally, 206030 people were diagnosed with MDR-TB in 2019, representing a 10% increase from 186883peo-ple who had it in 2018. In Uganda, the prevalence of MDR among new TB cases is 4.4% and 17.7% among previously treated TB cases.Aim: To determine the risk factors associated with MDR-TB among tuberculosis patients in Gulu regional referral hospital.Material and Methods: A cross-sectional analytical study using both quantitative and qualitative methods of data collection and analysis was used. Data was collected from 384 TB patients using data extraction form and 6 Key informant interviews conducted. Analysis using Pearson chi-square test was run.Results: HIV positive patients were 2.6 times more likely to be infected with MDR-TB than HIV negative patients [AOR=2.6: 95% CI 1.34- 5.85: P=0.006]. Previously treated TB patients were 2.8 times more likely to be infected with MDR-TB than newly diagnosed TB patients [AOR=2.8: 95% CI 1.33- 5.85: P=0.006]. Defaulting TB patients were 3.1 times more likely to be infected with MDR-TB than the non-defaulting TB patients [AOR=3.1]Conclusion: There is high prevalence of drug resistance among patients attending TB treatment at the facility.
引用
下载
收藏
页码:343 / 357
页数:15
相关论文
共 50 条
  • [1] Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda
    Batte, Charles
    Namusobya, Martha S.
    Kirabo, Racheal
    Mukisa, John
    Adakun, Susan
    Katamba, Achilles
    AFRICAN HEALTH SCIENCES, 2021, 21 (01) : 238 - 247
  • [2] RISK FACTORS OF MULTI-DRUG RESISTANT TUBERCULOSIS (MDR TB) IN NEPAL
    Marahatta, S. B.
    Kaewkungwal, J.
    Ramasoota, P.
    Singhasivanon, P.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A344 - A345
  • [3] Multi-drug resistant TB (MDR-TB) and HIV; the effect of introducing molecular testing for MDR-TB at a regional centre in Uganda
    Namuyodi, D.
    Meadway, J.
    Olupot-Olupot, P.
    HIV MEDICINE, 2014, 15 : 144 - 144
  • [4] Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
    Aurin, Tafsina Haque
    Munshi, Saurab Kishore
    Kamal, S. M. Mostofa
    Rahman, Md. Mostafizur
    Hossain, Md. Shamim
    Marma, Thaythayhla
    Rahman, Farjana
    Noor, Rashed
    PLOS ONE, 2014, 9 (06):
  • [5] Multi-drug resistant tuberculosis (MDR-TB) in the Free State, South Africa in 2012
    van Dijk, A. Van der Spoel
    Wojno, J.
    Hoosen, A. A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 78 - 78
  • [6] Cycloserine induced delirium during treatment of multi-drug resistant tuberculosis (MDR-TB)
    Saraf, Gayatri
    Akshata, J. S.
    Kuruthukulangara, Seby
    Thippeswamy, Harish
    Reddy, Senthil Kumar
    Buggi, Shashidhar
    Chaturvedi, Santosh K.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2015, 64 (02): : 449 - 451
  • [7] Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia
    Demile, Biresaw
    Zenebu, Amare
    Shewaye, Haile
    Xia, Siqing
    Guadie, Awoke
    BMC INFECTIOUS DISEASES, 2018, 18
  • [8] Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia
    Biresaw Demile
    Amare Zenebu
    Haile Shewaye
    Siqing Xia
    Awoke Guadie
    BMC Infectious Diseases, 18
  • [9] Multi-Drug Resistance Tuberculosis (MDR-TB) Challenges in India: A Review
    Vishwakarma, Deepak
    Gaidhane, Abhay
    Sahu, Sweta
    Rathod, Ashwini S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [10] MULTI-DRUG RESISTANT TUBERCULOSIS (MDR-TB) TREATMENT IN THE UK: A SURVEY OF INJECTABLE USE AND TOXICITY IN PRACTICE
    Sturdy, A.
    Goodman, A.
    Jose, R. J.
    Loyse, A.
    O'Donoghue, M.
    Kon, O. M.
    Dedicoat, M. J.
    Harrison, T.
    John, L.
    Lipman, M.
    Cooke, G.
    THORAX, 2010, 65 : A4 - A5